News

OCRF Research Finds Combination Immunotherapy Promising

OCRF Research Finds Combination Immunotherapy Promising

August 19, 2015

(August 19, 2015) Whereas chemotherapy kills cancer cells only while it is being administered, immunotherapy can lead to an adaptive immune response that persists long after treatment is ceased. By simple analogy, whereas aspirin provides temporary pain relief, a polio vaccine provides lifelong protection. Unfortunately, just as tumors develop resistance to conventional therapies, tumors also … Continued

OCRA News

Ovarian Cancer Survival Rates Higher Than Thought

Ovarian Cancer Survival Rates Higher Than Thought

August 17, 2015

(August 17, 2015) A study from the University of California, Davis found that one-third of women with ovarian cancer survive at least 10 years after diagnosis. The study, published in the Journal of Obstetrics and Gynecology, linked high survival rates with younger ages, early stages, and tumor type but they also found many exceptions to … Continued

Research

New York Times Letter to the Editor

New York Times Letter to the Editor

August 13, 2015

On August 3, 2015 the New York Times published an article about the use of IP chemotherapy in the treatment of ovarian cancer. Our CEO, Calaneet Balas joined with Ovarian Cancer Research Fund CEO, Audra Moran, to write a response to the New York Times. Click the plus sign to see their Letter to the Editor.

OCRA News

The New York Times Publishes OCRF’s Letter to the Editor 8/...

The New York Times Publishes OCRF’s Letter to the Editor 8/12/15

August 12, 2015

(8/12/15) In response to the article “An Ovarian Cancer Treatment, Recommended Since 2006, is Found to be Underused,“ published in the Health section of The New York Times on August 3, 2015, OCRF co-wrote a Letter to the Editor along with Ovarian Cancer National Alliance, strongly encouraging physicians and treatment centers to fully consider and communicate all treatment … Continued

OCRA News

Ovarian Cancer Research Fund and National Sponsor QVC Expan...

Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman Program

August 10, 2015

Gynecologic Cancer Patients to Receive Support in 6 New Locations WEST CHESTER, Pa (August 10, 2015) —Ovarian Cancer Research Fund (OCRF) and QVC today announced six new Woman to Woman grant recipients: Cooper University Hospital, Camden, New Jersey; Shanti Project/Kaiser Permanente, San Francisco, California; Northside Hospital Cancer Center, Atlanta, Georgia; The University of Alabama at … Continued

OCRA News

Study Finds Intraperitoneal Chemotherapy Underutilized

Study Finds Intraperitoneal Chemotherapy Underutilized

August 4, 2015

(August 4, 2015) A study published online in the Journal of Clinical Oncology reports that although the use of intraperitoneal chemotherapy (IP)/IV chemotherapy increased significantly at major cancer centers between 2003 and 2012, fewer than 50% of eligible patients received it. Previous studies have shown that the use of IP chemotherapy significantly improves survival among … Continued

Research

Partner Member Profile: Ovarian Cancer Alliance of Oregon a...

Partner Member Profile: Ovarian Cancer Alliance of Oregon and Southwest Washington

August 1, 2015

2015 marks the 10th anniversary of the Ovarian Cancer Alliance of Oregon and Southwest Washington, a Partner Member organization dedicated to spreading awareness through education, providing support to women and their families, and advocating for awareness and research funding. When Diane Rader O’Conner met Diane Elizondo while undergoing treatment for ovarian cancer, they realized the … Continued

Community

OCRF Research Finds Gene Therapy May Help Patients with Rec...

OCRF Research Finds Gene Therapy May Help Patients with Recurrent Ovarian Cancer

July 30, 2015

(July 30, 2015) Recurrent ovarian cancer patients have more hope today, thanks to OCRF-funded research by David Pepin, PhD at Massachusetts General Hospital. Dr. Pepin and his colleagues found that gene therapy that delivers a protein that suppresses the development of female reproductive organs may improve survival rates in patients with ovarian cancer that has … Continued

OCRA News

Younger Women with Low Grade Ovarian Cancer Face Worse Outc...

Younger Women with Low Grade Ovarian Cancer Face Worse Outcomes

July 29, 2015

(July 29, 2015) Research published online in the Journal of Clinical Oncology shows that upon completion of primary therapy, women with low-grade serous carcinoma of the ovary (LGSOC) or peritoneum (LGSPC) who are under the age of 35 and have persistent disease face worse outcomes. Researchers at the University of Texas MD Anderson Cancer Center … Continued

Research

OCRF Research Shows PARP/Immune Therapy Combo Shows Promise

OCRF Research Shows PARP/Immune Therapy Combo Shows Promise

July 23, 2015

(July 23, 2015) New OCRF-funded research demonstrates that combining a PARP-inhibitor with immune therapy results in tumor rejection and long-term survival in a mouse model of BRCA1-deficient ovarian cancer.  The study, published in Cancer Immunology Research, was funded by an OCRF Liz Tilberis Early Career Award to Sarah Adams, MD. The benefit of this combination … Continued

OCRA News

Comparison of Clear Cell and Serous Ovarian Cancer- Charact...

Comparison of Clear Cell and Serous Ovarian Cancer- Characteristics and Prognosis

July 21, 2015

(July 21, 2015) A group of Chinese researchers compared clinical characteristics and prognosis between ovarian clear cell carcinoma (CCC) and serous carcinoma (SC), and found that women with ovarian CCC presented at a younger age and early stage. Patients with ovarian CCC also had a longer time to recurrance, but they had similar overall survival … Continued

Research

QVC Heads to the Hamptons for Annual Charitable Broadcast

QVC Heads to the Hamptons for Annual Charitable Broadcast

July 21, 2015

QVC and Ovarian Cancer Research Fund Joining Forces for “QVC Presents Super Saturday LIVE” Broadcast WEST CHESTER, Pa. (July 21, 2015) – Help advance the fight against ovarian cancer with stylish steals and dazzling deals. QVC and Ovarian Cancer Research Fund (OCRF) are uniting once again for “QVC Presents Super Saturday LIVE,” an annual designer … Continued

Events